Search

Author/Creator Wehrli, Marc

4. Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5‐fluorouracil toxicity. Issue 8 (30th March 2021)

Authors:
Hamzic, Seid; Schärer, Dominic; Offer, Steven M.; Meulendijks, Didier; Nakas, Christos; Diasio, Robert B.; Fontana, Stefano; Wehrli, Marc; Schürch, Stefan; Amstutz, Ursula; Largiadèr, Carlo R.
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 8(2021)
Page Start:
3234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Siglec-7/-9 ligands shield tumor cells from NK cell attack. (7th November 2013)

Authors:
Jandus, Camilla; Boligan, Kayluz Frias; Chijioke, Obinna; Liu, He; Dahlhaus, Meike; Démoulins, Thomas; Schneider, Christoph; Wehrli, Marc; Hunger, Robert E; Baerlocher, Gabriela M; Simon, Hans-Uwe; Romero, Pedro; Münz, Christian; von Gunten, Stephan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS). Issue 1 (7th January 2022)

Authors:
Wehrli, Marc; Gallagher, Kathleen; Chen, Yi-Bin; Leick, Mark B; McAfee, Steven L; El-Jawahri, Areej R; DeFilipp, Zachariah; Horick, Nora; O'Donnell, Paul; Spitzer, Thomas; Dey, Bimal; Cook, Daniella; Trailor, Michael; Lindell, Kevin; Maus, Marcela V; Frigault, Matthew J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗